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Abstract
Introduction: Patients with rheumatoid arthritis (RA) are at an increased risk for cardiovascular disease (CVD). One
of the earliest manifestations of CVD is endothelial dysfunction (ED), which can lead to functional and
morphological vascular abnormalities. Several non-invasive assessments of vascular function and morphology can
be utilised to assess vascular health, but little is known about the association between each of these assessments
in patients with RA, and they tend to be used interchangeably in the literature. The objective of the present study
was to examine associations between measures of vascular function and morphology in patients with RA.
Methods: A total of 201 RA patients (155 females, median (25th to 75th percentile) age: 67 (59 to 73)) underwent
assessments of microvascular endothelium-dependent and endothelium-independent function (laser Doppler
imaging with iontophoresis of acetylcholine and sodium-nitroprusside respectively), macrovascular endothelium-
dependent and endothelium-independent function (flow-mediated dilatation and glyceryl-trinitrate-mediated
dilation respectively), and vascular morphology (pulse wave analysis, carotid intima-media thickness (cIMT), and
carotid plaque).
Results: Spearman’s correlations revealed that from the functional parameters, only macrovascular endothelium-
independent function was inversely associated with cIMT (-0.294 (P < 0.001)) after applying the Bonferroni
correction for multiple comparisons. For carotid plaque, t tests showed that macrovascular endothelium-
independent function was lower in patients with plaque than without (15.5 ± 8.3 vs. 23.1 ± 9.1%, P = 0.002,
respectively).
Conclusions: With the exception of macrovascular endothelium-independent function, all other measures of
vascular function were not associated with vascular morphology. This suggests that different assessments of
vascular function and morphology in patients with RA reflect quite distinct mechanisms and phases of the
atherosclerotic process and should not be used interchangeably.
Introduction
The endothelium is the innermost layer of the vascula-
ture and is responsible for maintaining an atheroprotec-
tive environment within the vessel. Damage to the
endothelium from injurious stimuli such as oxidative
stress and inflammatory mediators results in endothelial
dysfunction (ED) [1]. ED occurs in the early stages of
atherosclerosis, and reflects a reduction in the anti-athero-
genic molecule, nitric oxide (NO) [2]. In a healthy vessel,
NO is tonically released by endothelial cells to modulate
vasomotion, and counter the effects of pro-atherogenic
molecules such as endothelin-1 (ET-1) [1]. However, con-
tinued reduction in NO levels allows ET-1 to increase,
resulting in vascular inflammation and subsequent plaque
development [3,4]. These vascular alterations can lead to
a loss in vasodilatory function, arteriosclerosis, and
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development of advanced atherosclerosis. Several non-
invasive assessments of vascular function and morphology
can examine different stages of sub-clinical atherosclerosis
and provide useful information on an individual’s CVD
risk status.
During early atherosclerosis, a reduction in NO bioa-
vailability results in reduced vasodilatation along with
the promotion of platelet aggregation and leukocyte
adhesion to the vascular wall [5,6]. Assessments which
stimulate endothelial release of NO can be used to
examine vasodilatory function in the peripheral circula-
tion and serve as an index of early vascular damage [1].
Endothelial function should be examined in the micro-
vasculature and the macrovasculature due to heteroge-
neous responses to stimulation between these vascular
beds [7]. At present, the gold standard assessment of
peripheral endothelial function in the microvasculature
is laser Doppler imaging with Iontophoresis of NO
agonists and in the macrovasculature is flow-mediated
dilatation (FMD) (endothelium-dependent) and glyceryl-
trinitrate-mediated dilatation (GTN) (endothelium-inde-
pendent) [1]. These assessments correlate well with
assessments of coronary endothelial function [8-10].
Studies have shown that changes in endothelial function
are usually transient [11] and can be reversed with treat-
ment [12].
If factors that reduce NO bioavailability are not appro-
priately controlled then endothelial dysfunction can pro-
gress to arteriosclerosis (arterial stiffness) [13]. Arterial
stiffness typically occurs in medium to large arteries and
is due to degeneration of elastin fibres and deposition of
collagen into the vascular wall [14]. A reduction in NO
bioavailability and loss of smooth muscle tone also lead
to arteriosclerosis, which suggests that this stage of
atherosclerosis involves both functional and morphologi-
cal alterations to the vascular wall [15]. Arterial stiffness
can be measured using pulse wave analysis (PWA),
which measures the pulse pressure wave in the radial
artery and then calculates the central aortic pressure
waveform [1]. The consequences of arterial stiffening
include insufficient myocardial perfusion leading to
angina and myocardial infarction, and left ventricular
hypertrophy, which results in heart failure [14]. Arterial
stiffness also associates with a number of CVD risk fac-
tors such as ageing, smoking, dyslipidemia and hyper-
tension [16], and correlates with assessments of the
coronary vasculature [17].
Assessment of advanced, but subclinical, atherosclero-
sis can be carried out by examination of carotid artery
intima-media thickness (cIMT) and by determining the
presence of carotid plaques [1]. Thickening of the med-
ial layer of the vessel reflects several atherosclerotic pro-
cesses that stem from a reduction in NO levels and the
concomitant elevation in ET-1 levels; this leads to
increased production of pro-inflammatory cytokines,
leukocyte adhesion, activation of thrombotic factors,
proliferation of smooth muscle cells and formation of
lipid-rich plaques [18]. High-resolution B mode ultraso-
nography is typically used to visualise the carotid artery
in different anatomical locations and is a good predictor
of future cardiac events in patients with early athero-
sclerosis [19]. Recent evidence also suggests that deter-
mining the susceptibility for plaque rupture may be an
additional and important factor to consider when exam-
ining subclinical atherosclerosis [20].
Rheumatoid arthritis (RA) is a chronic systemic
inflammatory musculoskeletal disease [21]. Patients with
RA have an elevated risk of cardiovascular disease
(CVD) possibly due to similarities in the inflammatory
process in RA and atherosclerosis [22]. There is ample
evidence of both functional and morphological abnorm-
alities in the vasculature in RA [12]. At present, little is
known on whether assessments of vascular function and
morphology can be used interchangeably to provide an
index of global endothelial function in RA or whether
they should only be used to reflect the distinct stages of
atherosclerosis. Indeed, associations between functional
and morphological assessments are evident in some
cross-sectional studies (see Table 1) [23-25], but studies
examining the longitudinal effects of anti-inflammatory
medication in RA reveal that some aspects of vascular
function, but not morphology, may improve after treat-
ment [26-28]. This suggests that vascular function and
morphology might be distinctly affected by RA.
In other populations there is conflicting evidence on
whether such assessments correlate with each other (see
Table 1). In healthy participants, the majority of studies
report no association between functional and morpholo-
gical vascular assessments [29-32], but some studies in
patients with coronary artery disease (CAD) and diabetes
find associations between vascular function and morphol-
ogy [33,34]. However, the findings of these studies are
difficult to interpret due to a difference in population
characteristics (for example age, gender) and technical
aspects of measurement (for example automated or man-
ual vascular boundary detection) between studies.
To the best of our knowledge, there are no studies that
have specifically examined correlations between microvas-
cular endothelial function and morphological abnormal-
ities in the vasculature, despite research suggesting that
inflammatory mediators produced as a result of microvas-
cular injury may contribute to the formation of athero-
sclerotic lesions in the macrovessels [35]. In addition,
several studies report that endothelium-independent
function may be more readily affected by CVD risk fac-
tors in patients with cardiovascular disease [36,37] and in
RA [38], yet there is a dearth of studies examining the
relationship between endothelium-independent function
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and morphological parameters. Moreover, there is only
one small study in patients with CAD that has assessed
associations between macrovascular endothelial function
and presence of plaque, and found no association [39].
The prevalence of plaque is increased in RA [20], and
further research examining vascular predictors of plaque
is required.
The aim of the present study was to examine whether
microvascular and macrovascular endothelial function
associate with arteriosclerosis and carotid atherosclerosis
in order to understand whether these distinct assess-
ments of atherosclerosis are independent or related to
each other in patients with RA.
Methods
A total of 201 consecutive RA patients were recruited
from the rheumatology outpatient clinics of the Dudley
Group NHS Foundation Trust, United Kingdom. All
patients met the retrospective application of the 1987
revised RA criteria of the American College of Rheuma-
tology [40]. The study received ethics approval from
The Black Country Research Ethics Committee. All par-
ticipants gave their written informed consent according
to the Declaration of Helsinki.
Protocol
Patients reported to a temperature-controlled vascular
laboratory (22°C) after a 12-hour overnight fast. All
patients underwent a detailed clinical examination and
demographic information was collected by question-
naire. The disease activity score in 28 joints (DAS28)
[41] was also calculated. Following this, patients under-
went several functional and morphological vascular
assessments including laser Doppler imaging with
Table 1 Studies assessing the relationship between functional and morphological measures of endothelial function.
Authors Participants Vascular assessment Associations
Healthy
Juonala et al. 2004 [52] 2109 healthy (age: 32 ± 5 years) FMD, cIMT FMD inversely associated with cIMT
Yeboah et al. 2008 [29] 2338 healthy (age 78 ± 4) FMD, cIMT No significant associations
Koivistoinen et al. 2012 [30] 1754 healthy (young) (age: 30 - 45)
& 336 healthy (older) (age: 46 - 76)
FMD, PWV, cIMT No significant associations
Lunder et al. 2012 [50] 100 healthy males (age: 42 ± 6) FMD, GTN, PWV, cIMT FMD inversely associated with PWV
Irace et al. 2006 [31] 77 healthy FMD, GTN, cIMT No significant associations
Yan et al. 2005 [32] 1,578 healthy males (age: 49 ± 10) FMD, GTN, cIMT No significant associations
Coronary artery disease
Rohani et al. 2005 [39] 58 CAD (age: 67 ± 9) FMD, cIMT, carotid plaque No significant associations
Simova et al. 2008 [33] 198 CAD (age: 60 ± 10 FMD, cIMT FMD inversely associated with cIMT
Furumoto et al. 2002 [34] 45 CAD (age: 61 ± 11) FMD, GTN, cIMT FMD inversely associated with cIMT
Hashimoto et al. 1999 [53] 34 CAD males (age: 61 ± 2) & 33
age-matched healthy controls
FMD, GTN, cIMT FMD inversely associated with cIMT when both
populations combined, and when analysis was
performed in healthy controls only
&
GTN inversely associated with cIMT when both
populations combined
Enderle et al. 1998
[54]
101 CAD (age: 60 ± 8.6) & 21 non-
CAD (age: 57 ± 8.2)
FMD, GTN, cIMT FMD inversely associated with cIMT
Diabetes
Ravikumar et al. 2002
[55]
50 diabetics (age: 54 ± 10) & 50
healthy age- & sex-matched
controls
FMD, AIx, cIMT FMD inversely associated with AIx and cIMT
when both populations combined, and when
analysis was performed in healthy controls only
&
FMD inversely associated with AIx in diabetics
Rheumatoid arthritis
Arosio et al. 2007 [23] 65 RA females (age: 41 - 52) FMD, PWV FMD inversely associated with PWV in RA
Kerekes et al. 2008 [25] 52 RA (age: 51 ± 12) FMD, GTN, cIMT FMD inversely associated with cIMT
Soltesz et al. 2009
[24]
101 patients with autoimmune
disease (age: 52 ± 13)
FMD, AIx, PWV, cIMT FMD inversely associated with AIx, PWV and
cIMT
Van Doornum et al. 2003
[60]
25 RA (age: 46 ± 8) FMD, GTN, PWA FMD not associated with PWA
AIx, augmentation index; cIMT, carotid intima-media thickness; CAD, coronary artery disease; FMD, flow-mediated dilatation; GTN, glyceryl-trinitrate mediated
dilatation; PWV, pulse wave velocity; RA, rheumatoid arthritis.
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Iontophoresis of acetylcholine (ACh) and sodium nitro-
prusside (SNP)(microvascular endothelial function),
FMD and GTN (macrovascular endothelial function),
PWA (augmentation index (AIx)), cIMT as well as
assessment of carotid plaque (carotid atherosclerosis).
Microvascular endothelial function
Endothelial function of the microvasculature was
assessed non-invasively using LDI (Moor LDI 2 SIM;
Moor Instruments Ltd, Axminster, UK) with iontophor-
esis of 1% ACh (Miochol-E; Novartis, Frimley, UK) and
1% SNP (Nitroprussiat Fides, Rottapharm Madaus, Bar-
celona, Spain) in 2.5 ml solution containing 0.5% saline
by a single observer (AS). The technique was performed
according to previously established guidelines [42] and
has been described in detail previously [43]. Briefly, after
a baseline scan, 10 scans were recorded during ionto-
phoresis of the vasoactive agents using a 30 μA current,
followed by two scans during recovery. This technique
has an intra-observer co-efficient of variation (CV) for
ACh and SNP of 6.5% and 5.9% respectively in our
laboratory.
Macrovascular endothelial function
Assessment of macrovascular endothelium-dependent
function was performed using FMD with high-resolution
ultrasonography of the brachial artery (Acuson Antares
ultrasound system, Siemens PLC, Camberley, UK)
according to previously established guidelines [44].
Endothelium-independent responses were examined by
administration of a 500 microgram sublingual glyceryl-
trinitrate (GTN) tablet (Alpharma, Barnstaple, UK). The
intra-observer CV for the study ultrasonographer (AS)
was 10.7% for FMD and 11.8% for GTN assessments
respectively. For all vascular tests, endothelial function
was expressed as the percentage increase in perfusion or
diameter from baseline, and all analysis was carried out
offline by AS who was blinded to the identity of the
patient.
Pulse wave analysis
Pulse wave analysis (SphygmoCor Px Pulse Wave Analy-
sis, ScanMed Medical Instruments, Moreton in Marsh,
UK) was used to determine AIx as previously described
[45]. In brief, an applanation tonometer was positioned
over the left radial artery to measure the central aortic
waveform. The waveform is calibrated against the bra-
chial blood pressure and contains information on the
AIx (calculated as the difference between the second
and first systolic peaks and is expressed as a percentage
of the pulse pressure). The pressure waveforms in the
radial artery were recorded for an 11-second period.
The software integrated in the analyser displayed an
operator index that reflects the quality of the recorded
waveform. If the operator index was low (<75), another
reading was taken. Three readings with an operator
index >75 were used for analysis. For each parameter,
the average of the three readings was calculated.
Carotid atherosclerosis
High-resolution ultrasonography of the carotid artery
was performed by an experienced ultrasonographer (AS)
according to previously established guidelines [46] using
a 10 MHz linear array probe attached to the same high-
resolution ultrasound scanner as for the FMD assess-
ment. The cIMT was defined by determining the thick-
ness between the lines of Pignoli; with the first
echogenic line representing the lumen-intima interface,
and the second line representing the media-adventitia
interface [47]. Assessments of cIMT were performed in
the far wall, 1 cm proximal to the carotid bulb at sites
free of plaque in both the right and left common carotid
arteries using the longitudinal scanning plane. Three
measurements were taken on each side, and these were
averaged to give the mean IMT for the right and left
carotid arteries separately. The IMT from both sides
were further averaged to give the overall IMT.
The presence of carotid plaque was identified by scan-
ning the right and left common carotid artery, as well as
the internal and external carotid arteries. Carotid pla-
ques were defined as a focal structure encroaching into
the arterial lumen of at least 0.5 mm or 50% of sur-
rounding IMT value, or an IMT value of >1.5 mm [46].
The relative echogenicity of the plaques were evaluated
using the Artery Measurement Software (AMS, Stock-
holm, Sweden), which is an automated software specifi-
cally developed for analysis of gray-scale median (GSM)
as previously described [48]. Analysis of cIMT and the
presence of plaque were performed by a single observer
(AS) who was blinded to the identity of the patient. The
intra-observer CV for cIMT was 8.6%.
Statistical analysis
Statistical analysis was performed using IBM SPSS ver-
sion 20 (IBM Corp., Armonk, NY, USA). Continuous
variables were tested for normality, and expressed as
median (25 to 75th percentile values) or mean ± stan-
dard deviation, as applicable, with binary variables
expressed as percentages. Spearman’s correlation coeffi-
cients were used to assess the relationships between
functional and morphological parameters of endothelial
dysfunction. Associations between presence of carotid
plaque (dependent variable) and other vascular para-
meters (independent variables) were then assessed using
t tests and Mann-Whitney tests, as appropriate. A P
value of 0.05 was deemed to be indicative of signifi-
cance, although this was Bonferroni corrected where
necessary to account for multiple comparisons. Power
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calculations indicated that, for the intended sample size,
a correlation coefficient of 0.25 could be detected
between functional and structural assessments of
endothelial function at 80% power, with alpha of 0.006
(equivalent to 0.05 after Bonferroni adjustment for eight
comparisons). For the effect of carotid plaque, detectable
differences in the functional assessments of endothelial
function ranged from 33% to 50%, at 80% power with
alpha of 0.006.
Results
The patient characteristics are presented in Table 2. The
majority of patients were female, had long disease dura-
tion but moderate disease activity levels. The median
percentage increase in perfusion to ACh was 201%
(quartiles: 103 to 390), and for SNP was 132% (56 to
218). In the macrovasculature, mean FMD values were
10.6 ± 7.1%, and the GTN values were 21.7 ± 9.0%.
Assessment of PWA revealed that the mean AIx was
32.8 ± 9.1%. Assessment of carotid atherosclerosis
yielded a mean cIMT score of 0.69 ± 0.14 mm, with 16
patients showing evidence of plaque in the right carotid
artery, and 15 patients showing plaque in the left carotid
artery.
Spearman correlations were used to examine associa-
tions between functional and morphological parameters
of endothelial function. This analysis revealed only one
significant correlation, after adjustment for multiple
comparisons, with GTN being inversely associated with
cIMT (Table 3). For carotid plaque, it was found that
plaques in the right carotid artery were significantly
associated with percentage dilation to GTN (Table 4).
Where plaque was present in the right carotid artery,
the mean GTN was 15.5 ± 8.3, compared to 23.1 ± 9.1
where no plaque was evident (P = 0.002).
Discussion
The findings of the present study reveal that, in RA, only
macrovascular endothelium-independent function asso-
ciated with carotid atherosclerosis - a marker of advanced
morphological vascular alterations. To the best of our
knowledge, only two studies have directly examined asso-
ciations between endothelial function and carotid athero-
sclerosis in RA, with both studies reporting associations
between macrovascular endothelium-dependent function
and cIMT [24,25]. However, in one study [24] a hetero-
geneous sample of patients presenting with a variety of
autoimmune diseases (RA: n = 14) were recruited, which
does not allow for direct comparisons to the present
work. In the other study [25], only a small sample of RA
patients were assessed (n = 52) and macrovascular
endothelium-dependent function was considerably lower
than those reported in our study (5% and 11% respec-
tively); thus, it is possible that in patients with preserved
macrovascular endothelium-dependent function, an asso-
ciation with carotid atherosclerosis is unlikely.
Studies examining the longitudinal effects of anti-
inflammatory medication in RA have revealed that
microvascular and macrovascular endothelium-depen-
dent function, but not vascular morphology, improved
following treatment [26-28]. Furthermore, patients with
early RA, showed adverse changes in cIMT at 18-month
follow-up relative to baseline, but no change in macro-
vascular endothelium-dependent function [49]. A similar
effect is present when examining functional aspects of
the microvasculature and the macrovasculature [38].
Taken together, these findings support the present find-
ings and suggest that RA-associated systemic inflamma-
tion may exert differential effects on vascular function
and morphology in RA.
Studies in other populations have yielded mixed find-
ings; in healthy participants, five out of the six studies
included in Table 1 reported no significant associations
between macrovascular endothelium-dependent function
and carotid atherosclerosis [29,30,32,50,51]. Only Juonala
and colleagues [52] reported an association between
macrovascular endothelium-dependent function and caro-
tid atherosclerosis, but their study was confounded by a
high CV (26%) for the macrovascular endothelium-
dependent function measurement, which may affect the
accuracy of their data. In patients with CAD, one study
found no association between macrovascular endothe-
lium-dependent function and carotid atherosclerosis [39],
with other studies reporting associations between vascular
function and morphology [33,34,53,54]. However, these
studies do have caveats and should therefore be inter-
preted with caution. For example, Simova and colleagues
[33] found only a weak correlation between functional
and morphological parameters and this was no longer
significant when adjusting for presence of CAD, number
Table 2 General and disease-related characteristics for




Age (years) 67 (59-73)
Sex female N (%) 155 (77)
Body mass index 28 (24-32)
Disease-related characteristics
Disease duration (years) 16 (11-25)
Rheumatoid factor positive N (%)* 113 (81)
DAS28 3.1 (2.5-4.0)




Results are expressed as median (25th to 75th percentile values) or number
(percentage). *Data only available for 140 patients. DAS28, disease activity
score in 28 joints.
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of diseased coronary arteries and percentage coronary
artery stenosis [33]. In addition, some of the studies
included only small sample sizes (n = 34 to 101)
[34,53,54], or only found associations when combining
patients and healthy controls, but not in patients alone
[53,55]. The use of manual detection (rather than auto-
mated detection) of the vascular wall also decreased accu-
racy of obtained data in three of the studies [33,34,53].
Finally, the inconsistent findings between studies may
also be due to publication bias in the literature; with stu-
dies that find no association between functional and mor-
phological parameters less likely to be published. This
may have important implications for future study designs
and hypotheses.
The absence of an association between functional and
morphological assessments of the vasculature may be due
to a time lag between endothelial dysfunction and subse-
quent lesion development. In the study by Hashimoto and
colleagues [53], several participants with atherosclerosis
had normal cIMT, but decreased macrovascular endothe-
lium-dependent function, thus highlighting that functional
abnormalities may precede morphological abnormalities.
Indeed, when examining only functional parameters,
microvascular dysfunction often precedes macrovascular
dysfunction in RA [56] and in diabetes [57], with both vas-
cular beds being independent from each other in RA [58].
Interestingly, one study reported an association between
intima-media thickness of the brachial and carotid arteries,
but no association between brachial artery endothelium-
dependent function and carotid atherosclerosis [39]. This
suggests that functional and morphological abnormalities
reflect distinct atherosclerotic processes.
In the present study, macrovascular endothelium-inde-
pendent function associated with carotid atherosclerosis.
Such an association was not surprising as both assess-
ments (to varying degrees) reflect a reduction in smooth
muscle relaxation, smooth muscle hypertrophy as well
as proliferation of smooth muscle cells [1]. Nevertheless,
the association highlights the importance of assessing
smooth muscle dysfunction in patients at risk of CVD.
In healthy individuals with presence of CVD risk factors,
macrovascular endothelium-independent dysfunction
can occur independently of endothelium-dependent dys-
function [36]. Furthermore, macrovascular endothelium-
independent function, but not macrovascular endothe-
lium-dependent function was related to a reduction in
systolic blood pressure (SBP) after 12 and 24 weeks of
anti-hypertensive treatment in patients with hyperten-
sion [37]. Previous work in RA has also revealed that
macrovascular endothelium-independent function
associates with several classical CVD risk factors [38], all
of which are implicated in the development of carotid
artery lesions [59]. Collectively, these findings suggest
that abnormalities in macrovascular endothelium-inde-
pendent function can occur without concomitant
abnormalities in macrovascular endothelium-dependent
function, and that macrovascular endothelium-indepen-
dent function is related to morphological changes in the
vasculature. However, further detailed prospective stu-
dies examining this relationship are warranted.
Table 3 Correlations between functional and structural assessments of endothelial function.
Arterial stiffness Carotid intima-media thickness
Microvascular endothelial function
ACh (%) -0.027 (P = 0.729) -0.159 (P = 0.043)*
SNP (%) 0.049 (P = 0.524) -0.055 (P = 0.487)
Macrovascular endothelial function
FMD (%) 0.170 (P = 0.028)* -0.131 (P = 0.104)
GTN (%) 0.025 (P = 0.671) -0.294 (P < 0.001)**
Data displayed as Spearman’s rho coefficient (P value). *Significant at P < 0.05; **significant after Bonferroni adjustment for eight comparisons at P < 0.006. ACh,
acetylcholine; SNP, sodium nitroprusside; FMD, flow-mediated dilatation; GTN, glyceryl-trinitrate mediated dilatation.
Table 4 Effect of plaque on functional assessments of endothelial function.
Evidence of left plaque Evidence of right plaque
No Yes P value No Yes P value
Microvascular endothelial function
ACh (%) 242.5 (128.3-454.5) 179.5 (95.5-274.5) 0.092 262.0 (130.7-462.0) 152.0 (102.3-214.3) 0.032*
SNP (%) 144.0 (75.5-243.5) 120.0 (23.0-205.0) 0.221 140.5 (74.0-244.0) 143.0 (58.8-223.8) 0.700
Macrovascular endothelial function
FMD (%) 10.8 ± 7.2 10.5 ± 9.1 0.866 10.9 ± 7.4 9.7 ± 6.8 0.537
GTN (%) 22.7 ± 9.2 17.2 ± 9.7 0.061 23.1 ± 9.1 15.5 ± 8.3 0.002**
Microvascular endothelial function data displayed as: median (quartiles), with P values from Mann-Whitney tests. Macrovascular endothelial function data
displayed as mean ± standard deviation, with P values from t tests. *Significant at P < 0.05; **significant after Bonferroni adjustment for eight comparisons at
P < 0.006. ACh, acetylcholine; SNP, sodium nitroprusside; FMD, flow-mediated dilatation; GTN, glyceryl-trinitrate mediated dilatation.
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The strengths of the present work are the inclusion of a
large sample of patients, which provided adequate statisti-
cal power for the analysis. Additionally, measurements of
microvascular and macrovascular endothelium-dependent
and -independent function, along with assessments of
arteriosclerosis and carotid atherosclerosis allowed
detailed characterisation of each stage of atherosclerosis.
However, some limitations include the cross-sectional
study design, which does not determine cause-effect rela-
tionships. Further prospective studies are required to see
which measures of endothelial function and vascular
morphology are able to predict the development of future
cardiac events.
In conclusion, the present work highlights that, with
the exception of macrovascular endothelium-independent
function, assessments of vascular function and morphol-
ogy cannot be used interchangeably to assess vascular
health. Examination of endothelial function should incor-
porate functional and morphological assessments to
provide information on global endothelial dysfunction.
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